Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amphotericin B Cholesteryl Sulfate Complex for Invasive Fungal Diseases
NCT06376201Phase 4Not yet recruiting
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Apr 2024
- Primary completion
- Feb 2025
- Modality
- Recombinant Proteins and Enzymes, Nanoparticles
01
Overview
A Phase 4 trial of amphotericin b cholesteryl sulfate complex in invasive fungal disease (IFD), sponsored by Nanfang Hospital, Southern Medical University. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
amphotericin b cholesteryl sulfate complex
03
Conditions
invasive fungal disease (IFD)
Beyond the preview
Go deeper on NCT06376201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06376201.